Biomembrane Model Interaction and Percutaneous Absorption of Papaverine Through rat Skin: Effects of Cyclodextrins as Penetration Enhancers

References

• Abrams S. B., Yager P. Perturbation of the chain melting transition of DPPC by galactose, agarose and laurdan as determined by differential scanning calorimetry. Biochim. Biophys. Acta 1993; 1146: 127–135
   PubMed Web of Science ®Google Scholar
• Anselmi E., Fayos G., Blasco R., Candenas L., Cortes D., D'Ocon P. Selective inhibition of calcium entry induced by benzylisoquinolines in rat smooth muscle. J. Pharm. Pharmacol. 1992; 44: 337–343
   PubMed Web of Science ®Google Scholar
• Barry B. W. Dermatological Formulations: Percutaneous Absorption. Dekker, New York 1983
   Google Scholar
• Barry B. W. Mode of action of penetration enhancers in human skin. J. Control. Release 1987; 6: 84–97
   Google Scholar
• Bentley M. V.L.B., Vianna R. F., Wilson S., Collet J. H. Characterization of the influence of some CyDs on the stratum corneum from the hairless mouse. J. Pharm. Pharmacol. 1997; 49: 397–402
   PubMed Web of Science ®Google Scholar
• Berndt S. F., Schultz H. U., Stock K. Influence of PAP derivatives on phosphodiesterase activity, cyclic 3′,5′-AMP levels and relaxing effect on rabbit ileum. Naunyn-Schmiedeberg's Arch. Pharmacol. 1976; 294: 271–275
   Google Scholar
• Bouwstra J. A., Gooris G. S., Cheng K., Weerheim A., Bras W., Ponec M. Phase behavior of isolated skin lipids. J. Lipid Res. 1996; 37: 999–1011
   PubMed Web of Science ®Google Scholar
• Breukink E., Van Kraaij C., Van Dalen A., Demel R. A., Siezen R. J., De Kruijff B., Kuipers O. P. The orientation of nisin in membranes. Biochemistry 1998; 37: 8153–8162
   PubMed Web of Science ®Google Scholar
• Brewster M. E. Parenteral safety and applications of 2-hydroxypropyl-β-cyclodextrin. New Trends in Cyclodextrins and Derivatives, D. Duchene. Edition de Sante, Paris 1991; 313–350
   Google Scholar
• De Bruin D., Dormehl I. C., Du Plessis D. J., Jacobs L., Hugo N., Maree M. Prostaglandin El and papaverine: a comparative study on the ability to increase the penile bloodpool as measured by the 99mTC-penogram in the baboon model. Am. J. Physiol. Imaging 1991; 6: 129–132
   PubMedGoogle Scholar
• Djedaïni F., Zhao Lin S., Perly B., Wouessidjewe D. High-field nuclear magnetic resonance techniques for the investigation of a β-cyclodextrin indomethacin inclusion complex. J. Pharm. Sci. 1990; 79: 643–646
   PubMed Web of Science ®Google Scholar
• Duchěne D. Cyclodextrins and their Industrial Uses. Edition de Santé, Paris 1987
   Google Scholar
• Elias P. M. Epidermal lipids, barrier function, and desquamation. J. Invest. Dermatol. 1983; 80: 44–49
   PubMed Web of Science ®Google Scholar
• El Rashidy R. Topical composition containing a peripheral vasodilator and an absorption enhancer and methods for treatment of male impotence. PCT Int. Appl. WO 92/03141 1992
   Google Scholar
• Fartasch M. The nature of the epidermal barrier: structural aspects. Adv. Drug. Deliv. Rev. 1996; 18: 273–282
   Web of Science ®Google Scholar
• Franz T. J. Percutaneous absorption: on the relevance of in vitro data. J. Invest. Dermatol. 1975; 64: 190–195
   PubMed Web of Science ®Google Scholar
• Fresta M., Villari A., Puglisi G., Cavallaro G. 5-Fluorouracil: various kinds of loaded liposomes: encapsulation efficiency, storage stability and fusogenic properties. Int. J. Pharm. 1993; 99: 145–156
   Web of Science ®Google Scholar
• Fresta M., Ventura C. A., Puglisi G. (1998) Kinetic interaction of various β-cyclodextrins widi a DPPC biomembrane model. Second World Meeting on Pharmaceutics, Biopharmaceutics, Pharmaceutical Technology. 1998. Paris, 725–726
   Google Scholar
• Frijlink H. W., Eissens A. C., Hefting N. R., Poelstra K., Lerk C. F., Meijer D. K.F. The effect of parenterally administered cyclodextrins on cholesterol levels in the rat. Pharm. Res. 1991a; 8: 9–16
   PubMed Web of Science ®Google Scholar
• Frijlink H. W., Franssen E. J., Eissens A. C., Oosting R., Lerk C. The effect of cyclodextrins on the disposition of intravenously injected drugs in the rat. Pharm. Res. 1991b; 8: 380–384
   PubMed Web of Science ®Google Scholar
• Ganza-Gonzalez A., Vila-Jato J. L., Anguiano-Igea S., Otero-Espinar F. J., Blanco-Mendez J. A proton nuclear magnetic resonance study of the inclusion complex of naproxen with β-cyclodextrin. Int. J. Pharm. 1994; 106: 179–185
   Web of Science ®Google Scholar
• Hauser H., Strauss G. Stabilization of small, unilamellar phospholipid vesicles by sucrose during freezing and dehydration. Adv. Exp. Med. Biol. 1988; 238: 71–80
   PubMedGoogle Scholar
• Higuchi T., Connors K. A. Phase-solubility techniques. Adv. Anal. Chem. Instrum. 1965; 4: 117–212
   Google Scholar
• Irie T., Wakamatsu K., Arima H., Aritomi H., Uekama K. Enhancing effects of cyclodextrins on nasal absorption of insulin in rats. Int. J. Pharm. 1992; 84: 129–139
   Web of Science ®Google Scholar
• Jain M. K. Order and dynamics in bilayers and solute in bilayets. Introduction to Biological Membranes, M. K. Jain. Wiley, New York 1988; 122–165
   Google Scholar
• Jorgensen K., Ipsen J. H., Mouritsen O. G., Bennet D., Zuckermann M. J. A general model for the interaction of foreign molecules with lipid membranes: drugs and anaesthetics. Biochim. Biophys. Acta 1991; 1062: 227–238
   PubMed Web of Science ®Google Scholar
• Kitson N. J., Thewalt M., Lafleur M., Bloom M. A model membrane approach to epidermal permeability barrier. Biochemistry 1994; 33: 6707–6715
   PubMed Web of Science ®Google Scholar
• Komatsu H., Suzuki M. Percutaneous absorption of buthylparaben through guinea pig skin. “in vitro”, J. Pharm. Sci. 1979; 68: 596–598
   PubMed Web of Science ®Google Scholar
• Lohner K., Latal A., Lehrer R. I., Ganz T. Differential scanning microcalorimetry indicates that human defensin HNP-2, interacts specifically with biomembrane mimetic systems. Biochemistry 1997; 36: 1525–1531
   PubMed Web of Science ®Google Scholar
• Mannhold R. Inhibition of calmodulin-dependent cAMP phosphodiesterase by moxaverine and papaverine. Arzneim.-Forsch. 1988; 38: 1806–1808
   PubMed Web of Science ®Google Scholar
• Másson M., Loftsson T., Másson G., Stefánsson E. Cyclodextrins as permeation enhancers: some theoretical evaluations and in vitro testing. J. Control. Release 1999; 59: 107–118
   PubMed Web of Science ®Google Scholar
• Melnik B. C., Hollmann J., Erler E., Verhoeven B., Plewig G. Microanalytical screening of all major stratum corneum lipids by sequential high-performance thin-layer chromatography. J. Invest. Dermatol. 1989; 92: 231–234
   PubMed Web of Science ®Google Scholar
• Ohtani Y., Irie T., Uekama K., Fukunaga K., Pitha J. Differential effects of α,-β-and -γ-cyclodextrins on human erythrocytes. Eur. J. Biochem. 1989; 186: 17–22
   PubMedGoogle Scholar
• Okamoto H., Komatsu H., Hashida M., Sezaki M. Effects of β-cyclodextrin and di-O-methyl-β-cyclodextrin on the percutaneous absorption of butylparaben, indomethacin and sulfanilic acid. Int. J. Pharm. 1986; 30: 35–45
   Web of Science ®Google Scholar
• Okumura M., Nakamori Y., Yoshida Y., Niwa H., Sugibayashi K., Morimoto Y. Effect of monoglycerides on the percutaneous absorption of papaverine hydrochloride. Drug Des. Deliv. 1990; 6: 137–148
   PubMedGoogle Scholar
• Okumura M., Nakamori Y., Sugibayashi K., Morimoto Y. Enhanced skin permeation of papaverine by a medium chain glyceride. Drug Des. Deliv. 1991; 7: 147–157
   PubMedGoogle Scholar
• Ongpipattanakul B., Franceur M. L., Potts R. O. Polymorphism in stratum corneum lipids. Biochim. Biophys. Acta 1994; 1190: 115–122
   PubMed Web of Science ®Google Scholar
• Puglisi G., Fresta M., Ventura C. A. Interaction of natural and modified B-cyclodextrins with a biological membrane model of dipalmitoylphosphatidylcholine. J. Colloid Interf. Sci. 1996; 180: 542–547
   Web of Science ®Google Scholar
• Ronald V. Papaverine-containing drug for the treatment of impotence. Eur. Pat. Appl. EP 1991; 408/440
   Google Scholar
• Rubin D. Method and composition for treating impotence. U.S. Patent 1991; 5/059603
   Google Scholar
• Shao Z., Krishnamoorthy R., Mitra A. K. Cyclodextrins as nasal absorption promoters of insulin—mechanistic evaluations. Pharm. Res. 1992; 9: 1157–1163
   PubMed Web of Science ®Google Scholar
• Siguroardóttir A. M., Loftsson T. The effect of polyvinylpyrrolidone on cyclodextrin complexation of hydrocortisone and its diffusion through hairless mouse skin. Int. J. Pharm. 1995; 126: 73–78
   Web of Science ®Google Scholar
• Strauss G., Schurtenberger P., Hauser H. The interaction of saccharides with lipid bilayer vesicles: stabilization during freeze-thawing and freeze-drying. Biochim. Biophys. Acta 1986; 858: 169–180
   PubMed Web of Science ®Google Scholar
• Swartzendruber D. C., Wertz P. W., Madison K. C., Downing D. T. Evidence that the comeocyte has chemically bound lipid envelope. J. Invest. Dermatol. 1987; 88: 709–713
   PubMed Web of Science ®Google Scholar
• Tadashi K., Kiyotaka S., Kumiko A., Yoshiaki O., Toru T. Differences in responses to TC-81 among various arteries in dogs. J. Cardiovasc. Pharmacol. 1992; 20: 923–931
   PubMed Web of Science ®Google Scholar
• Van Duzee B. F. Thermal analysis of human stratum corneum. J. Invest. Dermatol. 1975; 55: 135–140
   Google Scholar
• Ventura C. A., Tirendi S., Puglisi G., Bousquet E., Panza L. Improvement of water solubility and dissolution rate of ursodeoxycholic acid and chenodeoxycholic acid by complexation with natural and modified β-cyclodextrins. Int. J. Pharm. 1997; 149: 1–13
   Web of Science ®Google Scholar
• Ventura C. A., Puglisi G., Zappala M., Mazzone G. A physico-chemical study on the interaction between papaverine and natural and modified β-cyclodextrins. Int. J. Pharm. 1998; 160: 163–172
   Web of Science ®Google Scholar
• Vollmer U., Müller B. W., Peeters J., Mesens J., Wilffert B., Peters T. A study of the percutaneous absorption enhancing effects of cyclodextrins derivatives in rats. J. Pharm. Pharmacol. 1994; 46: 19–22
   PubMed Web of Science ®Google Scholar
• Voss G., Eichler A. C. Method and ointment containing vasodilator for relieving impotence. U.S. Patent 1989; 4/801587
   Google Scholar
• Watanabe Y., Matsumoto Y., Kawamoto K., Yazawa S., Matsumoto M. Enhancing effect of cyclodextrins on nasal absorption of insulin and its duration in rabbits. Chem. Pharm. Bull. 1992a; 40: 3100–3104
   PubMed Web of Science ®Google Scholar
• Watanabe Y., Matsumoto Y., Seki M., Takase M., Matsumoto M. Absorption enhancement of polypeptide drugs by cyclodextrins. I. Enhanced rectal absorption of insulin from hollow-type suppositories containing insulin and cyclodextrins in rabbits. Chem. Pharm. Bull 1992b; 40: 3042–3047
   PubMed Web of Science ®Google Scholar
• Wertz P. M., Downing D. T. Stratum comeum: biological and biochemical considerations. Transdermal Drug Delivery, R. H. Guy, J. Hadgraft. Dekker, New York 1989; 1–22
   Google Scholar
• Williams M. L., Elias P. M. The extracellular matrix of stratum corneum: role of lipids in normal and pathological function. Crit. Rev. Ther. Drug Carrier Syst. 1987; 3: 95–122
   PubMed Web of Science ®Google Scholar
• Zhang D. D., Zhao P. Y., Huang N. J., Wu Y. L., Zhai Y. M. Study of H-NMR spectra of α-cyclodextrin or dimethylcyclodextrin/toluene complexes in CF3COOD/D20. Minutes of the Fifth International Symposium on Cyclodextrins, D. Duchěne. Editions de Sante, Paris 1990; 146–149
   Google Scholar